Dilshod Rafiev

2 ta ish

Tashkent Pediatric Medical Institute

1. Possibilities of long-term atezolizumab immunotherapy in patients with metastatic urothelial cancer.

   Sergey Kamishov, Mirzagaleb Tillyashaykhov, E. V. Boyko +5

   MaqolaBladder and Urothelial Cancer TreatmentsJournal of Clinical Oncology20240 iqtibos

   ABIABI:AkademIndex/2024.article.006417

2. The outcomes of atezolizumab therapy in combination with carboplatin and etoposide for small-cell lung cancer.

   Sergey Kamishov, Mirzagaleb Tillyashaykhov, Abrorjon Yusupbekov +6

   MaqolaOAOchiq kirishLung Cancer Research StudiesJournal of Clinical Oncology20240 iqtibos

   ABIABI:AkademIndex/2024.article.006753